Anti-LPIN1 monoclonal antibody

Pre-made anti-LPIN1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LPIN1/LPIN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2578-Ab-1/ GM-Tg-hg-IP2578-Ab-2Anti-Human LPIN1 monoclonal antibodyHuman
GM-Tg-rg-IP2578-Ab-1/ GM-Tg-rg-IP2578-Ab-2Anti-Rat LPIN1 monoclonal antibodyRat
GM-Tg-mg-IP2578-Ab-1/ GM-Tg-mg-IP2578-Ab-2Anti-Mouse LPIN1 monoclonal antibodyMouse
GM-Tg-cynog-IP2578-Ab-1/ GM-Tg-cynog-IP2578-Ab-2Anti-Cynomolgus/ Rhesus macaque LPIN1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2578-Ab-1/ GM-Tg-felg-IP2578-Ab-2Anti-Feline LPIN1 monoclonal antibodyFeline
GM-Tg-cang-IP2578-Ab-1/ GM-Tg-cang-IP2578-Ab-2Anti-Canine LPIN1 monoclonal antibodyCanine
GM-Tg-bovg-IP2578-Ab-1/ GM-Tg-bovg-IP2578-Ab-2Anti-Bovine LPIN1 monoclonal antibodyBovine
GM-Tg-equg-IP2578-Ab-1/ GM-Tg-equg-IP2578-Ab-2Anti-Equine LPIN1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2578-Ab-1/ GM-Tg-hg-IP2578-Ab-2; GM-Tg-rg-IP2578-Ab-1/ GM-Tg-rg-IP2578-Ab-2;
GM-Tg-mg-IP2578-Ab-1/ GM-Tg-mg-IP2578-Ab-2; GM-Tg-cynog-IP2578-Ab-1/ GM-Tg-cynog-IP2578-Ab-2;
GM-Tg-felg-IP2578-Ab-1/ GM-Tg-felg-IP2578-Ab-2; GM-Tg-cang-IP2578-Ab-1/ GM-Tg-cang-IP2578-Ab-2;
GM-Tg-bovg-IP2578-Ab-1/ GM-Tg-bovg-IP2578-Ab-2; GM-Tg-equg-IP2578-Ab-1/ GM-Tg-equg-IP2578-Ab-2
Products NameAnti-LPIN1 monoclonal antibody
Formatmab
Target NameLPIN1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LPIN1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2578-Ag-1Recombinant multi-species LPIN1/ PAP1 protein


    Target information

    Target IDGM-IP2578
    Target NameLPIN1
    Gene ID23175,14245,313977,697682,475670,101085623,537224,100072273
    Gene Symbol and Synonymsfld,Lipin1,LPIN1,PAP1
    Uniprot AccessionQ14693
    Uniprot Entry NameLPIN1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000134324
    Target ClassificationN/A

    The target: LPIN1, gene name: LPIN1, also named as PAP1. This gene encodes a magnesium-ion-dependent phosphatidic acid phosphohydrolase enzyme that catalyzes the penultimate step in triglyceride synthesis including the dephosphorylation of phosphatidic acid to yield diacylglycerol. Expression of this gene is required for adipocyte differentiation and it also functions as a nuclear transcriptional coactivator with some peroxisome proliferator-activated receptors to modulate expression of other genes involved in lipid metabolism. Mutations in this gene are associated with metabolic syndrome, type 2 diabetes, acute recurrent rhabdomyolysis, and autosomal recessive acute recurrent myoglobinuria (ARARM). This gene is also a candidate for several human lipodystrophy syndromes. [provided by RefSeq, Mar 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.